What is Integrated Micro-Chromatography Systems?
IMCS is a biotechnology firm focused on developing advanced tools and services for clinical and research laboratories. The company's product portfolio includes IMCSzyme®, a specialized enzyme collection for glycobiology research, and IMCStips®, a patented automated solid-phase extraction technology designed for efficient protein purification. By offering customized solutions for genomics, proteomics, and metabolomics, IMCS aims to streamline laboratory workflows and make complex research more accessible and affordable, thereby accelerating advancements in scientific understanding.
How much funding has Integrated Micro-Chromatography Systems raised?
Integrated Micro-Chromatography Systems has raised a total of $801K across 2 funding rounds:
Debt
$350K
Debt
$451K
Debt (2020): $350K with participation from PPP
Debt (2021): $451K led by PPP
Key Investors in Integrated Micro-Chromatography Systems
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Integrated Micro-Chromatography Systems?
With the recent major strategic investment, Integrated Micro-Chromatography Systems is well-positioned to expand its technological capabilities and market reach. The company is likely to invest in further research and development of its enzyme and extraction technologies, potentially broadening its application in areas like drug discovery and diagnostics. This capital infusion will also support scaling manufacturing processes and enhancing its service offerings to a wider client base in the genomics, proteomics, and metabolomics sectors. The strategic backing signals a strong confidence in IMCS's business model and its potential to lead in the glycobiology research tools market.
See full Integrated Micro-Chromatography Systems company page
